# A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G

> **NCT02388269** · NA · COMPLETED · sponsor: **ElectroCore INC** · enrollment: 91 (actual)

## Conditions studied

- Dyspepsia
- Irritable Bowel Syndrome

## Interventions

- **DEVICE:** gammaCore®-G

## Key facts

- **NCT ID:** NCT02388269
- **Lead sponsor:** ElectroCore INC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02388269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02388269, "A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02388269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*